A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma

Journal of Proteomics

Volumn 75, Issue 17, 2012, Pages 5507-5515

  Ahn, Yeong Hee ^a   Shin, Park Min ^a   Oh, Na Ree ^a   Park, Gun Wook ^a   Kim, Hoguen ^b   Yoo, Jong Shin ^a  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Aberrant glycosylation; Lectin; Liver cancer biomarker; Mass spectrometry; Multiple reaction monitoring

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; APOLIPOPROTEIN L1; BIOLOGICAL MARKER; C4B BINDING PROTEIN ALPHA CHAIN; CERULOPLASMIN; CLUSTERIN; COMPLEMENT COMPONENT C3; GLYCOPROTEIN; HEMOPEXIN; IMMUNOGLOBULIN MU CHAIN; LECTIN; OROSOMUCOID; UNCLASSIFIED DRUG; VITRONECTIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUCOSYLATION; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AMINO ACID SEQUENCE; BLOOD CHEMICAL ANALYSIS; CARBOHYDRATE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HUMANS; LECTINS; LIVER NEOPLASMS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PLASMA; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

ALEURIA AURANTIA; HEPATITIS B VIRUS;

EID: 84865540669     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.06.027     Document Type: Article

References (39)

1. Gomaa A.I., Khan S.A., Leen E.L., Waked I., Taylor-Robinson S.D. Diagnosis of hepatocellular carcinoma. World J Gastroenterol 2009, 15:1301-1314.
2. Moriwaki K., Miyoshi E. Fucosylation and gastrointestinal cancer. World J Hepatol 2010, 2:151-161.
3. Taylor A.D., Hancock W.S., Hincapie M., Taniguchi N., Hanash S.M. Towards an integrated proteomic and glycomic approach to finding cancer biomarkers. Genome Med 2009, 1:57.
4. Meany D.L., Zhang Z., Sokoll L.J., Zhang H., Chan D.W. Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns. J Proteome Res 2009, 8:613-619.
5. Ohyama C., Hosono M., Nitta K., Oh-eda M., Yoshikawa K., Habuchi T. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Glycobiology 2004, 14:671-679.
6. Peracaula R., Tabares G., Royle L., Harvey D.J., Dwek R.A., Rudd P.M., et al. Altered glycosylation pattern allows the distinction between prostate specific antigen (PSA) from normal and tumor origins. Glycobiology 2003, 13:457-470.
7. Miyoshi E., Ito Y., Miyoshi Y. Involvement of aberrant glycosylation in thyroid cancer. J Oncol 2010, 2010:816595.
8. Miyaaki H., Nakashima O., Kurogi M., Eguchi K., Kojiro M. Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma. J Gastroenterol 2007, 42:962-968.
9. Khien V.V., Mao H.V., Chinh T.T., Ha P.T., Bang M.H., Lac B.V., et al. Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma. Int J Biol Markers 2001, 16:105-111.
10. Zhao J., Qiu W., Simeone D.M., Lubman D.M. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. J Proteome Res 2007, 6:1126-1138.
11. Barrabés S., Pagès-Pons L., Radcliffe C.M., Tabarés G. Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. Glycobiology 2007, 17:388-400.
12. Pedersen J.W., Blixt O., Bennett E.P., Tarp M.A., Dar I., Mandel U., et al. Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. Int J Cancer 2011, 128:1860-1871.
13. Comunale M.A., Lowman M., Long R.E., Krakover J., Philip R., Seeholzer S., et al. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res 2006, 5:308-315.
14. Heo S.H., Lee S.J., Ryoo H.M., Park J.Y., Cho J.Y. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 2007, 7:4292-4302.
15. Yang Z., Hancock W.S., Chew T.R., Bonilla L. A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affinity chromatography coupled with RPLC-MS/MS. Proteomics 2005, 5:3353-3366.
16. Qiu Y., Patwa T.H., Xu L., Shedden K., Misek D.E., Tuck M., et al. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res 2008, 7:1693-1703.
17. Ahn Y.H., Lee J.Y., Lee J.Y., Kim Y.S., Ko J.H., Yoo J.S. Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry. J Proteome Res 2009, 8:4216-4224.
18. Liu Y., He J., Li C., Benitez R., Fu S., Marrero J., et al. Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations. J Proteome Res 2010, 9:798-805.
19. Kim Y.S., Son O.L., Lee J.Y., Kim S.H., Oh S., Lee Y.S., et al. Lectin precipitation using phytohemagglutinin-L(4) coupled to avidin-agarose for serological biomarker discovery in colorectal cancer. Proteomics 2008, 8:3229-3235.
20. Comunale M.A., Wang M., Hafner J., Krakover J., Rodemich L., Kopenhaver B., et al. Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J Proteome Res 2009, 8:595-602.
21. Breborowicz J., Mackiewicz A., Breborowicz D. Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand J Immunol 1981, 14:15-20.
22. Okuda H., Saito A., Shiratori K., Yamamoto M., Takasaki K., Nakano M. Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3. J Gastroenterol Hepatol 2005, 20:759-764.
23. Naitoh A., Aoyagi Y., Asakura H. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 1999, 14:436-445.
24. Kim Y.S., Kang H.Y., Kim J.Y., Oh S., Kim C.H., Ryu C.J., et al. Identification of target proteins of N-acetylglucosaminyl transferase V in human colon cancer and implications of protein tyrosine phosphatase kappa in enhanced cancer cell migration. Proteomics 2006, 6:1187-1191.
25. Kim Y.S., Hwang S.Y., Kang H.Y., Sohn H., Oh S., Kim J.Y., et al. Functional proteomics study reveals that N-Acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1. Mol Cell Proteomics 2008, 7:1-14.
26. Kuno A., Uchiyama N., Koseki-Kuno S., Ebe Y., Takashima S., Yamada M., et al. Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling. Nat Methods 2005, 2:851-856.
27. Pilobello K.T., Krishnamoorthy L., Slawek D., Mahal L.K. Development of a lectin microarray for the rapid analysis of protein glycopatterns. Chembiochem 2005, 6:985-989.
28. Chen S., LaRoche T., Hamelinck D., Bergsma D., Brenner D., Simeone D., et al. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat Methods 2007, 4:437-444.
29. Boja E., Hiltke T., Rivers R., Kinsinger C., Rahbar A., Mesri M., et al. Evolution of clinical proteomics and its role in medicine. J Proteome Res 2011, 10:66-84.
30. Boja E., Rivers R., Kinsinger C., Mesri M., Hiltke T., Rahbar A., et al. Restructuring proteomics through verification. Biomark Med 2010, 4:799-803.
31. Ahn Y.H., Kim Y.S., Ji E.S., Lee J.Y., Jung J.A., Ko J.H., et al. Comparative quantitation of aberrant glycoforms by lectin-based glycoprotein enrichment coupled with multiple-reaction monitoring mass spectrometry. Anal Chem 2010, 82:4441-4447.
32. Ahn Y.H., Kim K.H., Shin P.M., Ji E.S., Kim H., Yoo J.S. Identification of low-abundance cancer biomarker candidate TIMP1 from serum with lectin fractionation and peptide affinity enrichment by ultrahigh-resolution mass spectrometry. Anal Chem 2012, 84:1425-1431.
33. Ahn Y.H., Shin P.M., Ji E.S., Kim H., Yoo J.S. A lectin-coupled, multiple reaction monitoring-based quantitative analysis of human plasma glycoproteins by mass spectrometry. Anal Bioanal Chem 2012, 402:2101-2112.
34. Ahn Y.H., Ji E.S., Shin P.M., Kim K.H., Kim Y.S., Ko J.H., et al. A multiplex lectin-channel monitoring method for human serum glycoproteins by quantitative mass spectrometry. Analyst 2012, 137:691-703.
35. Curtis D. Comparison of artificial neural network analysis with other multimarker methods for detecting genetic association. BMC Genet 2007, 8:49.
36. Polanski M., Anderson N.L. A list of candidate cancer biomarkers for targeted proteomics. Biomarker Insights 2007, 7:1-48.
37. Schisterman E.F., Perkins N.J., Liu A., Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 2005, 16:73-81.
38. Comunale M.A., Rodemich-Betesh L., Hafner J., Wang M., Norton P., Di Bisceglie A.M., et al. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma. PLoS One 2010, 5:e12419.
39. Wang M., Long R.E., Comunale M.A., Junaidi O., Marrero J., Di Bisceglie A.M., et al. Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2009, 18:1914-1921.